Could ClinTex, the Estonia-based healthcare technology company, be ramping up its focus on artificial intelligence (AI) integration into the clinical trial process?
🔥Reach more than 5 000 000 real investors via Twitter influencer marketing! 🔥
ClinTex, the Estonia-based healthcare and De-Sci technology company, has been making significant strides in the adoption of cutting-edge technology in clinical trials. With the first release of their CTi-OEM app in August of 2021, followed closely in early 2022 by a Dfinity Foundation-funded early alpha version of Optex, a decentralized visualization layer for clinical data running on The Internet Computer, the company is showing no signs of slowing down.
New CT-Ai App
Now, with their latest blog posts and social media activity teasing about the team’s next upcoming app, CT-Ai, ClinTex appears to be ramping up its focus on artificial intelligence (AI) integration. While not many details are known about CT-Ai at this time, the company has made it clear that the core team is now focused on the machine learning integration part of their development.Â
This aligns with the company’s original whitepaper from 2018, which outlined the potential of AI learning in the clinical trial process and the concept of machine learning algorithms to analyze vast amounts of data and identify patterns that may not be immediately apparent to humans. As per the project’s core mission, this will lead to more efficient and effective clinical trials, resulting in faster approvals of new drugs and treatments to market, ultimately benefiting the health of the wider world.
ClinTex has already made waves in the healthcare technology space by utilizing blockchain technology to ensure the integrity of clinical trial data and automate many aspects of the process.
Clinical Trials in the UK
Earlier this year it was announced that CTi will be used on an upcoming clinical trial with LVL Health in the UK – The Clintex CTI tool will be implemented in the upcoming campaign trial being conducted by LVL Health, pending confirmation of the go-live date. The application of CTi is expected to increase the efficiency of the clinical trial and assist in the delivery of novel treatments and therapies. The Clintex team is thriving in the opportunity for collaboration with LVL health on this important novel clinical trial and more developments are on the horizon.
AI Integration Ahead
While CTi-OEM has already shown promise in improving the quality of data collected during trials, reducing costs, and accelerating the approval of new drugs and treatments, the next step of the integration of AI in the clinical trial process has the potential to completely revolutionize the DeSci (Decentralized Science) field.
As blockchain and AI both continue to push the boundaries of technology into industries such as clinical trials, the benefit to the wider world through upcoming innovative solutions looks very promising indeed.
Thank you for taking the time to read the article on ClinTex and their innovative approach to integrating AI into clinical trials. I hope that you found the information informative and interesting. If you have any further questions or would like to learn more about this topic, please feel free to ask.
🔥Reach more than 5 000 000 real investors via Twitter influencer marketing! 🔥
